Psyence Group Inc
Psyence Group Inc., a life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma. It operates in two segments, Clinical Trial Activities and Non-Clinical Trial Activities. The company develops botanical psilocybin-based psychedelic medicine, which works with natural psilocybin products for the h… Read more
Psyence Group Inc (PSYGF) - Total Liabilities
Latest total liabilities as of September 2025: $52.28K USD
Based on the latest financial reports, Psyence Group Inc (PSYGF) has total liabilities worth $52.28K USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Psyence Group Inc - Total Liabilities Trend (2016–2025)
This chart illustrates how Psyence Group Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Psyence Group Inc Competitors by Total Liabilities
The table below lists competitors of Psyence Group Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
New Mountain Finance Corporation
NASDAQ:NMFC
|
USA | $1.83 Billion |
|
Syncona Limited
LSE:SYNC
|
UK | GBX13.77 Million |
|
TRUBF
PINK:TRUBF
|
USA | $389.96 Million |
|
Nextage Therapeutics Ltd
TA:NXTG
|
Israel | ILA5.89 Million |
|
Crossroads Systems Inc
OTCQX:CRSS
|
USA | $1.60 Billion |
|
Margo Caribe Inc
PINK:MRGO
|
USA | $16.08 Million |
|
TEEKAY
MU:TCD
|
Germany | €229.98 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Psyence Group Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 16.88 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.06 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Psyence Group Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Psyence Group Inc (2016–2025)
The table below shows the annual total liabilities of Psyence Group Inc from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | $1.06 Million | -92.96% |
| 2024-03-31 | $15.11 Million | +466.35% |
| 2023-03-31 | $2.67 Million | +62.30% |
| 2022-03-31 | $1.64 Million | +1101.60% |
| 2021-03-31 | $136.77K | +126.11% |
| 2020-03-31 | $60.49K | -18.16% |
| 2019-03-31 | $73.91K | -36.06% |
| 2018-03-31 | $115.61K | +20.78% |
| 2017-03-31 | $95.72K | +54.47% |
| 2016-03-31 | $61.97K | -- |